Urinary Bladder Neoplasms: all 1,649 studies
Page 4 of 17. Open to participants first (427), then studies with results posted, then the rest; newest registration first within each.
- Safety Analysis and Oncological Outcomes in HoLERT vs TURBTRecruitingNCT05833997Not applicable
- Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)RecruitingNCT05825950
- Influence of Anesthesia Methods on CTCs in TURBT PatientsNot yet recruitingNCT05824299Not applicable
- Single-Dose Intravesical Chemotherapy After Diagnostic URSNot yet recruitingNCT05810623Phase 3
- Evaluating Safety and Efficacy of Prostate-sparing Radical CystectomyRecruitingNCT05792722Not applicable
- Multicentric Prospective T1 Urinary Bladder Cancer RegistryRecruitingNCT05792033
- Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)RecruitingNCT05790850Not applicable
- DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating MutationsRecruitingNCT05786716Phase 2/3
- Validity of Parametric MRI Using VIRADSRecruitingNCT05783271Not applicable
- Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging ParadigmRecruitingNCT05779631Not applicable
- Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant HistologyRecruitingNCT05756569Phase 2
- Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer PatientsRecruitingNCT05739968Not applicable
- JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder CancerEnrolling by invitationNCT05739071Not applicable
- The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)RecruitingNCT05726786Phase 3
- Patient-Centered Surgical PrehabilitationRecruitingNCT05715684Not applicable
- The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer PatientsRecruitingNCT05710159
- Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular VolumeNot yet recruitingNCT05701332Phase 4
- Comprehensive Geriatric Assessment for Perioperative Optimization in CystectomyRecruitingNCT05679557Not applicable
- Renal Retention in High Grade Upper Tract Urothelial CancerRecruitingNCT05656235Phase 2
- Gender Related Coping and Survivorship for Genitourinary CancersRecruitingNCT05649306
- Bladder Cancer Screening TrialRecruitingNCT05646485Not applicable
- Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized StudyRecruitingNCT05626101Not applicable
- Quantifying Systemic Immunosuppression to Personalize Cancer TherapyRecruitingNCT05621837
- FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3RecruitingNCT05614739Phase 1
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsRecruitingNCT05592626Phase 1/2
- Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder CancerNot yet recruitingNCT05580354Phase 4
- A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin CancerRecruitingNCT05562791Phase 1
- The Supraspinal Control of Lower Urinary Tract Function in Patients With Orthotopic Sigmoid Neobladder.RecruitingNCT05558111
- Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary CancersRecruitingNCT05519878Not applicable
- A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsRecruitingNCT05503797Phase 2
- Disitamab Vedotin Combined With Tislelizumab for Her2 Overexpressing High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely ResectableRecruitingNCT05495724Phase 2
- EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing CystectomyRecruitingNCT05480735Not applicable
- Personalized Urine Biomarker for Patients With Bladder CancerNot yet recruitingNCT05467267
- Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic AnalysisRecruitingNCT05464576Not applicable
- Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)RecruitingNCT05453682Not applicable
- Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder CancerNot yet recruitingNCT05445648Phase 2
- Augmented Bladder Tumor Detection Using Real Time Based Artificial IntelligenceRecruitingNCT05415631
- Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder CancerRecruitingNCT05401279Phase 2
- Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With HyperthermiaRecruitingNCT05397262Not applicable
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruitingNCT05366881
- An Open-label, Single-arm, Multicenter Phase II Clinical Study： Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder CancerNot yet recruitingNCT05356351Phase 2
- Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder CancerRecruitingNCT05337397
- A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in ChinaRecruitingNCT05337189
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
- Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter StudyRecruitingNCT05328336Phase 2
- Urinary Continence of Female POPRC and OINNot yet recruitingNCT05325216Not applicable
- Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder CancerRecruitingNCT05312671Phase 2
- A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder CancerRecruitingNCT05297552Phase 2
- Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerRecruitingNCT05267626Phase 1/2
- Lymphedema After Urologic SurgeryRecruitingNCT05264337
- OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder CancerRecruitingNCT05232136Phase 1/2
- PENK Methylation Test for Detecting Bladder CancerRecruitingNCT05220189
- Role of Microbiome in BCG Responsiveness PredictionRecruitingNCT05204199
- Impact of COMORBIDities After Radical Cystectomy Using a Predictive Method With Artificial IntelligenceRecruitingNCT05204186
- Preoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced UltrasonographyRecruitingNCT05204108
- Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder CancerRecruitingNCT05203913Phase 2
- The Impact of Late Effects After Treatment for Bladder Cancer on Quality of LifeEnrolling by invitationNCT05195515
- Bladder Cancer Detection Using Convolutional Neural NetworksRecruitingNCT05193656
- Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBCRecruitingNCT05123625Not applicable
- Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.RecruitingNCT05102110
- A Beta-only IL-2 ImmunoTherapY StudyRecruitingNCT05086692Phase 1/2
- Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder CancerRecruitingNCT05072600Phase 2
- Comparison Capsule Sparing Cystectomy and Radical Cystoprostatectomy in Men With Bladder CancerRecruitingNCT05067101Not applicable
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruitingNCT05059444
- Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)RecruitingNCT05037279Phase 3
- AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder CancerRecruitingNCT05002556
- LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder TumorsRecruitingNCT04979156
- Bio Clinical Collection of Urothelial CarcinomaRecruitingNCT04970472
- Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline)RecruitingNCT04947059Phase 3
- The Global En Bloc Resection of Bladder Tumour RegistryRecruitingNCT04934540
- A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract MalignanciesRecruitingNCT04923178
- Improving Care for Rural Patients With Solid TumorsRecruitingNCT04916990Not applicable
- Robotic Radical Cystectomy OutcomesRecruitingNCT04900558
- A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2RecruitingNCT04879329Phase 2
- An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)RecruitingNCT04876313Phase 2
- Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer SubjectsRecruitingNCT04861584Phase 2
- LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-NaïveRecruitingNCT04752722Phase 1/2
- A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC PatientsRecruitingNCT04736394Phase 3
- Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder CancerRecruitingNCT04724928Phase 2
- Sacituzumab Govitecan Plus EV in Metastatic UCRecruitingNCT04724018Phase 1/2
- En Bloc Bladder Tumor Resection: Prospective Randomized StudyRecruitingNCT04712201Not applicable
- Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial CarcinomaRecruitingNCT04588168Not applicable
- Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)RecruitingNCT04574960Phase 3
- Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesAvailableNCT04566393
- Predicting BCG ResponseRecruitingNCT04564781
- Nordic Cystectomy Study III - TransfusionRecruitingNCT04537221
- Impact of Remimazolam on Prognosis After Bladder Cancer SurgeryRecruitingNCT04532606Phase 4
- Nordic Cystectomy Study II - AlbuminRecruitingNCT04523038
- Nordic Cystectomy Study I - Neutrophil-lymphocyte Ratio (NLR)RecruitingNCT04523025
- Prospective Bladder Cancer Infrastructure (ProBCI)RecruitingNCT04503577
- Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapyRecruitingNCT04442724Not applicable
- Patient-Derived Xenografts to Reduce Cancer Health DisparitiesRecruitingNCT04410302
- A Study of Sigvotatug Vedotin in Advanced Solid TumorsRecruitingNCT04389632Phase 1
- Virtual Histology of the Bladder Wall for Bladder Cancer StagingRecruitingNCT04369560Early Phase 1
- CONFIRM: Magnetic Resonance Guided Radiation TherapyRecruitingNCT04368702Not applicable
- Influence of Hormone Treatment in Radiation Therapy for Bladder CancerRecruitingNCT04282876
- En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope DeviceRecruitingNCT04235764
- Prospective Collection of Samples for Urothelial Cancer of BladderNot yet recruitingNCT04167332
- Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid MalignanciesRecruitingNCT04149691Phase 1
- DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancErRecruitingNCT04106115Phase 1/2